Pelvic neoplasms in children

D B Groff1

  • 1Department of Surgery, Kosair Children's Hospital, Louisville, Kentucky 40202, USA.

Insights

Pediatric pelvic neoplasms require precise diagnosis and tailored treatment. Advances in chemotherapy and surgical techniques have significantly improved survival rates for these rare childhood cancers.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Developmental Anatomy

Background:

  • Childhood pelvic neoplasms present unique anatomical challenges compared to adults.
  • Congenital anomalies of the rectum and bladder influence treatment strategies.
  • Common pediatric pelvic tumors include rhabdomyosarcomas, sacrococcygeal teratomas, and germ cell tumors.

Purpose of the Study:

  • To highlight the evolving role of surgery in pediatric pelvic neoplasm treatment.
  • To emphasize the need for precise histologic and genetic tumor characterization.
  • To underscore the importance of multidisciplinary care in specialized children's cancer centers.

Main Methods:

  • Review of common pediatric pelvic neoplasms and their characteristics.
  • Discussion of advancements in chemotherapy and surgical approaches.
  • Analysis of the impact of children's cancer study groups on treatment outcomes.

Main Results:

  • Chemotherapy advancements have shifted surgical paradigms towards less radical resections.
  • Accurate tumor identification (histologic, genetic, and anatomic) is crucial for effective treatment.
  • Survival rates for childhood pelvic neoplasms have dramatically improved over the past two decades.

Conclusions:

  • Optimal management of pediatric pelvic neoplasms necessitates specialized care within major children's cancer centers.
  • Integrated treatment approaches combining chemotherapy, precise surgery, and genetic analysis are key to improved outcomes.
  • The complexity and improved survival rates warrant centralized, expert management for these conditions.